Embracing Bayesian Methods in Clinical Trials: FDA's Long-Awaited Draft Guidance.
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
American Medical Association (AMA)
Department of Pure Mathematics and Mathematical Statistics
https://doi.org/10.1001/jama.2026.4179
Department of Pure Mathematics and Mathematical Statistics
https://doi.org/10.1001/jama.2026.4179
Abstract
Description
This Perspective discusses the importance of the US Food and Drug Administration’s draft guidance on the use of bayesian methods in clinical trials because it underscores its commitment to modernizing clinical research.